Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Opdivo May Be the First Marketed in China, Chinese Pharmaceutical Enterprises are Catching up Fast!

ZhixingJanuary 17, 2018

Tag: NSCLC , monoclonal antibody , CFDA , Opdivo , PD-1

PharmaSources Customer Service